258 related articles for article (PubMed ID: 15063733)
1. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
Bohne J; Kräusslich HG
FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
[TBL] [Abstract][Full Text] [Related]
2. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
Marcello A; Zoppé M; Giacca M
IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
[TBL] [Abstract][Full Text] [Related]
3. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
Madore SJ; Cullen BR
Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
[TBL] [Abstract][Full Text] [Related]
4. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
West MJ; Karn J
EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
[TBL] [Abstract][Full Text] [Related]
7. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
Zhao C; Chen Y; Park J; Kim JB; Tang H
Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
[TBL] [Abstract][Full Text] [Related]
8. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
Kim YS
Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.
Mukhtar M; Duan L; Bagasra O; Pomerantz RJ
Gene Ther; 1996 Aug; 3(8):725-30. PubMed ID: 8854098
[TBL] [Abstract][Full Text] [Related]
10. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo.
Wright S; Luccarini C
J Mol Biol; 1996 Oct; 263(1):1-7. PubMed ID: 8890908
[TBL] [Abstract][Full Text] [Related]
11. The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms.
Lassot I; Latreille D; Rousset E; Sourisseau M; Linares LK; Chable-Bessia C; Coux O; Benkirane M; Kiernan RE
Mol Cell; 2007 Feb; 25(3):369-83. PubMed ID: 17289585
[TBL] [Abstract][Full Text] [Related]
12. Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes.
Chipitsyna G; Sawaya BE; Khalili K; Amini S
J Cell Physiol; 2006 Jun; 207(3):605-13. PubMed ID: 16511829
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
Desfosses Y; Solis M; Sun Q; Grandvaux N; Van Lint C; Burny A; Gatignol A; Wainberg MA; Lin R; Hiscott J
J Virol; 2005 Jul; 79(14):9180-91. PubMed ID: 15994812
[TBL] [Abstract][Full Text] [Related]
15. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
Niikura M; Dornadula G; Zhang H; Mukhtar M; Lingxun D; Khalili K; Bagasra O; Pomerantz RJ
Oncogene; 1996 Jul; 13(2):313-22. PubMed ID: 8710370
[TBL] [Abstract][Full Text] [Related]
17. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
[TBL] [Abstract][Full Text] [Related]
18. Attenuated and wild-type HIV-1 infections and long terminal repeat-mediated gene expression from plasmids delivered by gene gun to human skin ex vivo and macaques in vivo.
Kent SJ; Cameron PU; Reece JC; Thompson PR; Purcell DF
Virology; 2001 Aug; 287(1):71-8. PubMed ID: 11504543
[TBL] [Abstract][Full Text] [Related]
19. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A
Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313
[TBL] [Abstract][Full Text] [Related]
20. In silico mutagenesis of RNA splicing in HIV-1.
Kim H; Yin J
Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]